• OPEN AN ACCOUNT
Indian Indices
Sensex
78,428.95 -210.08
( -0.27%)
Global Indices
Nasdaq
53,210.99 704.96
(1.34%)
Dow Jones
7,621.51 110.79
(1.48%)
Hang Seng
63,983.92 229.02
(0.36%)
Nikkei 225
10,890.39 32.69
(0.30%)
Forex
USD-INR
95.40 -0.19
(-0.20%)
EUR-INR
110.00 0.21
(0.19%)
GBP-INR
128.60 0.50
(0.39%)
JPY-INR
0.61 0.01
(2.47%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Alkem Laboratories consolidated net profit declines 22.69% in the March 2026 quarter
May 28,2026
Net profit of Alkem Laboratories declined 22.69% to Rs 236.46 crore in the quarter ended March 2026 as against Rs 305.86 crore during the previous quarter ended March 2025. Sales rose 14.62% to Rs 3603.32 crore in the quarter ended March 2026 as against Rs 3143.75 crore during the previous quarter ended March 2025.

For the full year,net profit rose 6.30% to Rs 2301.80 crore in the year ended March 2026 as against Rs 2165.48 crore during the previous year ended March 2025. Sales rose 13.48% to Rs 14712.27 crore in the year ended March 2026 as against Rs 12964.52 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3603.323143.75 15 14712.2712964.52 13
OPM %14.3612.45 -20.4319.38 -
PBDT663.58508.83 30 3427.782884.19 19
PBT557.82396.34 41 3045.722527.03 21
NP236.46305.86 -23 2301.802165.48 6